You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 280 No. 1, July 1, 1998 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (17)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Topic Collections
 •HIV/AIDS
 •Immunology
 •Immunologic Disorders
 •Infectious Diseases
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

HIV/AIDS in 1998—Gaining the Upper Hand?

Oren J. Cohen, MD; Anthony S. Fauci, MD

JAMA. 1998;280:87-88.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

The global community that is dedicated to understanding, treating, and preventing human immunodeficiency virus (HIV) infection is gathering in Geneva, Switzerland, from June 28 through July 3, 1998, for the 12th International Conference on AIDS (acquired immunodeficiency syndrome). Whereas steady incremental advances characterized the field of HIV research throughout the first 10 international conferences on AIDS, the 11th conference in Vancouver, British Columbia, focused on quantum leaps within the areas of therapeutics (ie, introduction of protease inhibitors for use in combination antiretroviral regimens) and pathogenesis (ie, identification of chemokine receptors as HIV coreceptors). Early optimism regarding the possibility of eradication of HIV has yielded to the more realistic concept of long-term control of virus replication. In addition, the many obstacles to effective therapy for persons with HIV infection highlight the theme of 2 years ago, "much accomplished, much to do."1

Considerable optimism . . . [Full Text of this Article]

From the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

An overview of AIDS dementia complex
Meehan and Brush
AM J ALZHEIMERS DIS OTHER DEMEN 2001;16:225-229.
ABSTRACT  

Latent reservoirs of HIV: Obstacles to the eradication of virus
Chun and Fauci
Proc. Natl. Acad. Sci. USA 1999;96:10958-10961.
FULL TEXT  

Reconsidering targeted toxins to eliminate HIV infection: You gotta have HAART
Berger et al.
Proc. Natl. Acad. Sci. USA 1998;95:11511-11513.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1998 American Medical Association. All Rights Reserved.